Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia-Reference-Cited by-同舟云学术

Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia

Published:2012-01 Issue:1 Volume:22 Page:235-239
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Yang Shu-Wei,Smotryski Jennifer,McElroy William T.,Tan Zheng,Ho Ginny,Tulshian Deen,Greenlee William J.,Guzzi Mario,Zhang Xiaoping,Mullins Deborra,Xiao Li,Hruza Alan,Chan Tze-Ming,Rindgen Diane,Bleickardt Carina,Hodgson Robert

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference18 articles.

1. A Systematic Review of the Prevalence of Schizophrenia

2. Schizophrenia;Cancro,1989

3. Antipsychotics and QT prolongation

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Novel Quinolone and Quinazoline Alkaloids as Phosphodiesterase 10A Inhibitors for Parkinson’s Disease through a Computational Approach;ACS Omega;2024-03-26

2. A New Insight into the Synthesis and Biological Activities of Pyrazole based Derivatives;Mini-Reviews in Organic Chemistry;2022-09

3. 1H-Pyrazolo[3,4-b]quinolines: Synthesis and Properties over 100 Years of Research;Molecules;2022-04-26

4. Cyclic nucleotide phosphodiesterase inhibition as a potential therapeutic target in renal ischemia reperfusion injury;Life Sciences;2021-10

5. 5-Aminopyrazole-4-carbonitriles as precursors to novel 4-aminotetrahydropyrazolo[3,4-b]quinolin-5-ones and N-(4-cyanopyrazol-5-yl)pyridine-3-carbonitrile;Synthetic Communications;2021-06-14